Search Results - "GIGUERE, Pierre"

Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy by Miller, Caragh, Giguère, Pierre, McGuinty, Michaeline, Angel, Jonathan Benjamin

Get full text

Needs Assessment for Pharmacy Program Creation Designed to Serve Minority Francophone Populations in Canada by Gaudet, Julie, Giguère, Pierre, Thabet, Pierre, Hubert, Daniel, Moreau, Pierre, Landry, Christine

“…Current literature provides little insight into the need for French-language pharmaceutical services in Francophone minority settings in Canada. This study…”
Get full text

Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients by Giguère, Pierre, Deschenes, Marie-Josée, Van Loon, MacKenzie, Hoar, Stephanie, Fairhead, Todd, Pazhekattu, Rinu, Knoll, Greg, Karpinski, Jolanta, Parikh, Namrata, McDougall, Jessica, McGuinty, Michaeline, Hiremath, Swapnil

“…Nirmatrelvir/ritonavir has been shown to reduce the risk of coronavirus disease 2019 (COVID-19)-related complications in patients at high risk for severe…”
Get full text

Pritelivir for the treatment of nucleoside analogue–resistant orolabial herpes simplex virus 2 in a person living with HIV by Purssell, Andrew, Leung, Kennedy, Giguère, Pierre, Angel, Jonathan B

“…Background: Nucleoside analogue–resistant herpes simplex virus infections are increasingly observed especially in immunocompromised patients. Currently, other…”
Get full text

Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia by Mistry, Mielen, Shea, Amanda, Giguère, Pierre, Nguyen, My-Linh

“…Background: Hyperkalemia occurs frequently in an inpatient setting, for which sodium polystyrene sulfonate (SPS) is a common treatment modality. Few studies…”
Get full text

Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications by Giguère, Pierre, Nhean, Salin, Tseng, Alice L., Hughes, Christine A., Angel, Jonathan B.

“…The past 20 years have seen remarkable advances in the treatment of HIV such that most people diagnosed with HIV today can live long, healthy lives by taking…”
Get full text

Enhancing COVID Rehabilitation with Technology (ECORT): protocol for an open-label, single-site randomized controlled trial evaluating the effectiveness of electronic case management for individuals with persistent COVID-19 symptoms by Hatcher, Simon, Werier, Joel, Edgar, Nicole E, Booth, James, Cameron, D William J, Corrales-Medina, Vicente, Corsi, Daniel, Cowan, Juthaporn, Giguère, Pierre, Kaluzienski, Mark, Marshall, Shawn, Mestre, Tiago, Mulligan, Bryce, Orpana, Heather, Pontefract, Amanda, Stafford, Darlene, Thavorn, Kednapa, Trudel, Guy

“…As of May 2022, Ontario has seen more than 1.3 million cases of COVID-19. While the majority of individuals will recover from infection within 4 weeks, a…”
Get full text

Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High‐Dose Methotrexate by Drost, Sarah A., Wentzell, Jason R., Giguère, Pierre, McLurg, Darcy L., Sabloff, Mitchell, Kanji, Salmaan, Nguyen, Tiffany T.

“…Study Objectives Urine alkalinization increases methotrexate (MTX) solubility and reduces the risk of nephrotoxicity. The objectives of this study were to…”
Get full text

Efficacy, Safety, and Practicality of Tacrolimus Monitoring after Bone Marrow Transplant: Assessment of a Change in Practice by Cheung, Jacky, Wentzell, Jason, Trinacty, Melanie, Giguère, Pierre, Patel, Priya, Kekre, Natasha, Nguyen, Tiffany

“…Currently, there is no standardized approach to the frequency of monitoring tacrolimus levels in patients who have undergone hematopoietic stem cell transplant…”
Get full text

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment by Cooper, Curtis, Klein, Marina B., Conway, Brian, Barrett, Lisa, Giguère, Pierre, Tseng, Alice, Wong, Alex, Shafran, Stephen D., Hull, Mark, Haider, Shariq

“…Background. Hepatitis C virus (HCV) coinfection occurs in 20–30% of Canadians living with HIV and is responsible for a heavy burden of morbidity and mortality…”
Get full text

Canadian guideline on HIV preexposure prophylaxis and nonoccupational postexposure prophylaxis for pharmacists by Hughes, Christine, Yoong, Deborah, Giguère, Pierre, Hull, Mark, Tan, Darrell H. S.

Get full text

Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients by Chowdhry, Unnum, Jacques, Amanda, Karovitch, Alan, Giguère, Pierre, Nguyen, My-Linh

“…Recent approval of the new oral anticoagulants dabigatran and rivaroxaban has led to rapid changes in anticoagulant prescribing practices. Postmarketing…”
Get full text

Pharmacokinetics of darunavir, etravirine and raltegravir in an HIV-infected patient on haemodialysis by GIGUERE, Pierre, LA PORTE, Charles, GUIJUN ZHANG, CAMERON, Bill

“…The use of haemodialysis in HIV-infected patients with end-stage renal disease is common and may affect the pharmacokinetics of the antiretroviral drugs…”
Get full text

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults by Hull, Mark, Shafran, Stephen, Tseng, Alice, Giguère, Pierre, Klein, Marina B, Cooper, Curtis

“…Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV and is responsible for a heavy burden of morbidity and mortality…”
Get full text

Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia by TOY, Junine, GIGUERE, Pierre, KRAVCIK, Stephen, LA PORTE, Charles J. L

Get full text

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults by Hull, Mark, Klein, Marina, Shafran, Stephen, Tseng, Alice, Giguère, Pierre, Côté, Pierre, Poliquin, Marc, Cooper, Curtis

“…Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV, and is responsible for a heavy burden of morbidity and mortality…”
Get full text

Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult by Jacques, Amanda Caroline, Giguere, Pierre, Zhang, Guijun, Touchie, Claire, la Porte, Charles JL

“…OBJECTIVE To report a case of atazanavir-associated choledocholithiasis in an HIV-infected individual. CASE SUMMARY A 47-year-old treatment-naïve HIV-positive…”
Get full text

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis by Tan, Darrell H S, Hull, Mark W, Yoong, Deborah, Tremblay, Cécile, O'Byrne, Patrick, Thomas, Réjean, Kille, Julie, Baril, Jean-Guy, Cox, Joseph, Giguere, Pierre, Harris, Marianne, Hughes, Christine, MacPherson, Paul, O'Donnell, Shannon, Reimer, Joss, Singh, Ameeta, Barrett, Lisa, Bogoch, Isaac, Jollimore, Jody, Lambert, Gilles, Lebouche, Bertrand, Metz, Gila, Rogers, Tim, Shafran, Stephen

“…New HIV infections occur every year in Canada, highlighting the need for integrated prevention programs. Pre-exposure prophylaxis (PrEP) and nonoccupational…”
Get full text

Impact of an electronic tool in prescribing primary prophylaxis with ciprofloxacin or granulocyte colony-stimulating factor for breast cancer patients receiving TC chemotherapy by Sulpher, Jeffrey, Giguere, Pierre, Hopkins, Sean, Dent, Susan

“…Background The US Oncology Trial 9735 (doxorubicin and cyclophosphamide (AC) versus docetaxel and cyclophosphamide (TC)) reported febrile neutropenia (FN) in…”
Get full text

HIV-HCV Co-infection therapeutic outcomes have not improved over time by Cooper, Curtis, Costiniuk, Cecilia, Giguère, Pierre

Get more information